0001562180-22-001071.txt : 20220203
0001562180-22-001071.hdr.sgml : 20220203
20220203172926
ACCESSION NUMBER: 0001562180-22-001071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jarrett Jennifer
CENTRAL INDEX KEY: 0001671311
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 22589842
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 525 MARKET ST., 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-02-02
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001671311
Jarrett Jennifer
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
true
false
false
false
Common Stock
2022-02-02
4
A
false
16000.00
0.00
A
32000.00
D
Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control.
/s/ Michael A. Metzger, Attorney-in-Fact
2022-02-03
EX-24
2
jarrettpoa.htm
JARRETTPOA.HTM
POWER OF ATTORNEY
The undersigned, a member of the Board of Directors of Syndax
Pharmaceuticals, Inc., a Delaware corporation (the "Company"), hereby
constitutes and appoints Michael A. Metzger and Luke J. Albrecht, for so
long as each such person is an employee of the Company, and Laura Berezin,
for so long as she is a partner of a law firm representing the Company, the
undersigned's true and lawful attorney-in-fact, each with the power to act
alone for the undersigned and in the undersigned's name, place and stead, to:
1. Prepare, complete and execute Forms 3, 4 and 5 under the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and other forms
and all amendments thereto on the undersigned's behalf as such
attorney-in-fact shall in his or her discretion determine to be required or
advisable pursuant to Section 16 of the Exchange Act and the rules and
regulations promulgated thereunder, or any successor laws and regulations,
as a consequence of the undersigned's beneficial ownership of securities of
the Company or changes in such beneficial ownership; and
2. Do all acts necessary in order to file such forms and amendments with the
Securities and Exchange Commission, any securities exchange or national
association, the Company and such other persons or agencies as the
attorney-in-fact shall deem appropriate.
The undersigned hereby ratifies and confirms all that said attorneys-in-fact
and agents shall do or cause to be done by virtue hereof. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
or liability under Section 16 of the Exchange Act or any rules and
regulations promulgated thereunder or any successor laws and regulations.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, or 5 with respect to
the undersigned's beneficial ownership of securities of the Company or
changes in such beneficial ownership, unless earlier revoked by the undersigned
in a signed writing delivered to the Company and the foregoing
attorneys-in-fact.
The undersigned has executed this Power of Attorney as of September 27, 2018.
/s/ Jennifer Jarrett
Jennifer Jarrett